Alexander Group’s executive briefing outlines how provider priorities are reshaping MedTech’s go-to-market models.
In 2026, providers face shrinking reimbursement, rising expenses and significantly constrained capital budgets. With additional economic challenges from OBBBA-related revenue compression (67% expect NPR to decline by up to 10%), administrative efficiency, workforce productivity and financial flexibility have become central decision drivers.
To respond effectively, leading MedTech organizations are reallocating coverage, roles and post-sales support to execute five dominant commercial growth plays and stay ahead of the shifting landscape.
Increasing operational efficiency is the top priority across all respondent groups.
91% of organizations expect overall expenses to increase in 2026.
Capital budgets are expected to be more constrained than in 2025 and 2024.
-2.3% decrease in overall reimbursement projected by hospital executives.
OBBA is expected to have significant negative impact on healthcare provider’s net patient revenue.
67% expect OBBA to decrease NPR by up to 10%, and 8% expect it to decrease by greater than 10%.
AI technologies are expected to transform clinical decision making, and patient provider engagement.
72% of organizations expect to adopt AI for clinical decision-making purposes in the next 24 months.
Providers expect reps to be clinical experts, technically savvy, and to help them navigate the reimbursement journey.
57% of organizations state that lack of expertise in navigating reimbursement challenges is a key talent gap for Med Device reps.
Translate provider economics into GTM moves
Benchmark your commercial model
Refine non-acute and key account strategy
Unlock ROI from new product launches
Strengthen post-sales and lifetime value
Please complete the form and an Alexander Group representative will be in contact with you soon to schedule your briefing.